科研
教育
登录
CN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Division of Pharmacoengineering and Molecular Pharmaceutics,
UNC Eshelman School of Pharmacy,
Lineberger Comprehensive Cancer Center,
Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy
Shawn D. Hingtgen has not added Biography.
If you are Shawn D. Hingtgen and would like to personalize this page please email our Author Liaison for assistance.
Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases.
PloS one , 2013 | Pubmed ID: 23620794
Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.
Nanomedicine (London, England) Jul, 2014 | Pubmed ID: 24237263
Neural stem cell therapy for cancer.
Methods (San Diego, Calif.) Apr, 2016 | Pubmed ID: 26314280
Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells.
Nanomedicine : nanotechnology, biology, and medicine Apr, 2016 | Pubmed ID: 26586551
Fibrin matrices enhance the transplant and efficacy of cytotoxic stem cell therapy for post-surgical cancer.
Biomaterials Apr, 2016 | Pubmed ID: 26803410
Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma.
Nature communications , 2016 | Pubmed ID: 26830441
Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma.
Biomaterials Jun, 2016 | Pubmed ID: 27016620
Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model.
Neuro-oncology 12, 2016 | Pubmed ID: 27298311
Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.
Science translational medicine 02, 2017 | Pubmed ID: 28148846
Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.
Molecular pharmaceutics Mar, 2018 | Pubmed ID: 29342360
Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection.
PloS one , 2018 | Pubmed ID: 29990322
University of North Carolina at Chapel Hill
Kevin T. Sheets1,
Juli R. Bagó1,
Ivory L. Paulk1,
Shawn D. Hingtgen1,2
1Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill,
2Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
政策
使用条款
隐私
联系我们
向图书馆推荐
JoVE 新闻简报
JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
发表
图书馆员
访问权限
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。